Avoiding the Domino Effect: How Smarter Temperature Control and Excursion Management Prevent Clinical Trial Disruptions

When investigational medicinal products (IMPs) are exposed to improper storage conditions, sponsors must act quickly to protect trial integrity. Temperature excursions can compromise product stability, distort clinical data, endanger patients, and raise regulatory concerns. Operationally, they may delay timelines, increase costs, and damage reputations.

Given the complexity of modern trials and the sensitivity of biologics, sponsors must prevent excursions through proactive strategies and implement fast, reliable detection across the clinical supply chain. Learn more today from Sarah McAliskey, Temperature Services Manager at Almac Clinical Services in this IBI Article.